Physician profile
Caleb J Stepan
NPI 1023137940
$1,431.73
in general payments reported to CMS, 2019-2025
20 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $350 · 2021: $158 · 2022: $237 · 2023: $76.89 · 2024: $78.43 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $240.30 | 2021-2025 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $225.94 | 2019-2021 | |
| Astellas Pharma US INC | $156.23 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $128.46 | 2020-2021 | |
| Healthtronics Stone Solutions, LLC | $120.00 | 2020 | |
| Medtronic, INC. | $82.89 | 2022 | |
| Dendreon Pharmaceuticals LLC | $82.10 | 2025 | Provenge |
| Abbvie INC. | $53.91 | 2022 | |
| Axonics, INC. | $51.03 | 2022-2023 | Bulkamid, Axonics |
| Progenics Pharmaceuticals, INC. | $48.94 | 2022-2023 | Pylarify |
| Procept Biorobotics Corporation | $39.78 | 2025 | |
| Janssen Scientific Affairs, LLC | $34.50 | 2019 | |
| Pfizer INC. | $34.09 | 2022-2024 | |
| Myovant Sciences INC. | $30.84 | 2021-2022 | |
| Immunitybio, INC. | $23.50 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $18.24 | 2024 | |
| Sumitomo Pharma America, INC. | $17.99 | 2023 | Orgovyx |
| Myriad Genetic Laboratories, INC. | $16.97 | 2024 | Myrisk |
| Endo Pharmaceuticals INC. | $14.17 | 2023 | Aveed, Xiaflex |
| Urogen Pharma, INC. | $11.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Stepan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.